Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Pharmaceutical Research|March 23, 2004
Esterase-like activity of serum albumin: characterization of its structural chemistry using p-nitrophenyl esters as substratesYuji Sakurai, Shen-Feng Ma, Hiroshi Watanabe, et al.
Biochimica Et Biophysica Acta|November 22, 2007
Changes of net charge and alpha-helical content affect the pharmacokinetic properties of human serum albuminYasunori Iwao, Mikako Hiraike, Ulrich Kragh-Hansen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|October 16, 2012
Elucidation of the therapeutic enhancer mechanism of poly-S-nitrosated human serum albumin against multidrug-resistant tumor in animal modelsYu Ishima, Marie Hara, Ulrich Kragh-Hansen, et al.
Bioconjugate Chemistry|January 10, 2012
S-Nitrosated human serum albumin dimer is not only a novel anti-tumor drug but also a potentiator for anti-tumor drugs with augmented EPR effectsYu Ishima, Di Chen, Jun Fang, et al.
Nitric Oxide : Biology and Chemistry|February 14, 2013
UW solution improved with high anti-apoptotic activity by S-nitrosated human serum albuminYu Ishima, Takuya Shinagawa, Shinji Yoneshige, et al.
Journal of Structural Biology|March 30, 2010
Crystallographic analysis reveals a unique lidocaine binding site on human serum albuminKim Langmach Hein, Ulrich Kragh-Hansen, J Preben Morth, et al.
The Journal of Biological Chemistry|October 23, 2008
S-nitrosylated human serum albumin-mediated cytoprotective activity is enhanced by fatty acid bindingYu Ishima, Takaaki Akaike, Ulrich Kragh-Hansen, et al.
Biochimica Et Biophysica Acta|January 19, 2016
Mutants and molecular dockings reveal that the primary L-thyroxine binding site in human serum albumin is not the one which can cause familial dysalbuminemic hyperthyroxinemiaUlrich Kragh-Hansen, Lorenzo Minchiotti, Andrea Coletta, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 27, 2005
Hydrolysis of angiotensin II receptor blocker prodrug olmesartan medoxomil by human serum albumin and identification of its catalytic active sitesShen-Feng Ma, Makoto Anraku, Yasunori Iwao, et al.
IUBMB Life|February 22, 2012
Quantitative evaluation of the role of cysteine and methionine residues in the antioxidant activity of human serum albumin using recombinant mutantsYasunori Iwao, Yu Ishima, Junji Yamada, et al.
Pageof 6